Bruker Corporation is pleased to announce the closing of its acquisition of ELITechGroup for €870 million in cash, excluding the carved out ELITech clinical chemistry business. Going forward ...

Mirina, the new entity, gained Nanogen’s technology that aims to enhance miRNA drugs. Nanogen and The Elitech Group entered a definitive merger agreement. Separately, Nanogen also created a ...